Anuh Pharma82.86
+1.71 (+2.11%)

Anuh Pharma Share Price

82.86+1.71 (+2.11%)
-7.16% past 1 Year

Corporate filings & documents

Announcements

Newspaper Publication of the Unaudited Financial Results for the Quarter and half year ended 30th September 2026 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 01st November 2026.
3 days ago
Newspaper Publication of the Unaudited Financial Results for the Quarter and half year ended 30th September 2026 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 01st November 2026.
3 days ago
Request received for withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group" to "Public Category".
5 days ago
Request received for withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group" to "Public Category".
5 days ago
Unaudited Financial Results for the Quarter and half year ended 30th September 2026.
5 days ago
Unaudited Financial Results for the Quarter and half year ended 30th September 2026.
5 days ago
To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September 2026 and Request received for withdrawal of application for reclassification of shareholder from "Promoter and Promoter Group" to "Public Category".
5 days ago
To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September 2026 and Request received for withdrawal of application for reclassification of shareholder from "Promoter and Promoter Group" to "Public Category".
5 days ago
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2026 and to consider any other matter with the permission of the Chairman.
1 week ago
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2026 and to consider any other matter with the permission of the Chairman.
1 week ago
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2026 and to consider any other matter with the permission of the Chairman.
1 week ago
Intimation for receiving the possession of manufacturing facility
2 weeks ago
Intimation for receiving the possession of manufacturing facility
2 weeks ago
Disclosure of Events under Regulation 30 of SEBI LODR Regulation 2015 for signing of Asset Transfer Agreement
2 weeks ago
Disclosure of Events under Regulation 30 of SEBI LODR Regulation 2015 for signing of Asset Transfer Agreement
2 weeks ago
To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion
3 weeks ago
To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion
3 weeks ago
To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion
3 weeks ago
To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion
3 weeks ago
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants ) Regulation 2018 for the quarter ended 30th September 2026 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of the Company.
3 weeks ago
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants ) Regulation 2018 for the quarter ended 30th September 2026 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of the Company.
3 weeks ago
Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Thursday 01st October 2026 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30th September 2026.
1 month ago
Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Thursday 01st October 2026 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30th September 2026.
1 month ago
Disclosure under Regulation 30 of the SEBI LODR regarding receipt of Demand Order under Section 156 of the Income Tax Act 1961.
1 month ago
Disclosure under Regulation 30 of the SEBI LODR regarding receipt of Demand Order under Section 156 of the Income Tax Act 1961.
1 month ago
Investor Presentation for Q1 FY 2026-27
2 months ago
Investor Presentation for Q1 FY 2026-27
2 months ago
Disclosure under Regulation 30 of SEBI (LODR) 2015 regarding Change in Management.
2 months ago
Disclosure of Announcement under Regulation 30 of SEBI (LODR) 2015
2 months ago
Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company
2 months ago
Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company
2 months ago
Outcome of the 66th Annual General Meeting of Anuh Pharma Limited held on Wednesday 12th August 2026
2 months ago
Outcome of the 66th Annual General Meeting of Anuh Pharma Limited held on Wednesday 12th August 2026
2 months ago
Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June 2026 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 09th June 2026.
2 months ago
Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June 2026 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 09th June 2026.
2 months ago
Adoption of Revised Policy of Related Party Transactions.
2 months ago
Adoption of Revised Policy of Related Party Transactions.
2 months ago
Request received for Withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group to Public Category.
2 months ago
Request received for Withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group to Public Category.
2 months ago
Unaudited Financial Results for the Quarter ended 30th June 2026.
2 months ago
Unaudited Financial Results for the Quarter ended 30th June 2026.
2 months ago
To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter ended 30th June 2026 Request received for withdrawal of application for reclassification of shareholders from "Promoter and Promoter Group" to "Public Category" and Adoption of revised Policy on Related Party Transactions.
2 months ago
To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter ended 30th June 2026 Request received for withdrawal of application for reclassification of shareholders from "Promoter and Promoter Group" to "Public Category" and Adoption of revised Policy on Related Party Transactions.
2 months ago
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2026 and to consider any other matter with the permission of the Chairman.
3 months ago
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2026 and to consider any other matter with the permission of the Chairman.
3 months ago
This is to inform to the stock exchange regarding dispatch of physical communication to shareholders who have not registered their email address.
3 months ago
This is to inform to the stock exchange regarding dispatch of physical communication to shareholders who have not registered their email address.
3 months ago
Pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 that a meeting of the Shareholders of the Company will be held on Wednesday 12th August 2026 please find enclosed Newspaper Clipping of the Advertisement published on Saturday 18th July 2026 in the Financial Express (English) and Mumbai Lakshdeep (Marathi).
3 months ago
Pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 that a meeting of the Shareholders of the Company will be held on Wednesday 12th August 2026 please find enclosed Newspaper Clipping of the Advertisement published on Saturday 18th July 2026 in the Financial Express (English) and Mumbai Lakshdeep (Marathi).
3 months ago
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligation and Disclosures Requirements) Regulations 2015 please find enclosed herewith the copy of the Annual Report of the Company for the Financial Year 2025-26 for your information and records.
3 months ago

Concalls & investor presentations

Aug 2026
May 2026
Feb 2026
Aug 2025
May 2025
Nov 2024
Feb 2024
Aug 2023
May 2023
Feb 2023
Aug 2022
May 2022
ConcallPresentation
May 2022
May 2022
Feb 2022
ConcallPresentation
Feb 2022
Nov 2021
ConcallPresentation
Nov 2021
Aug 2021
ConcallPresentation
Aug 2021
May 2021
Feb 2021
ConcallPresentation
Feb 2021
Nov 2020

Anuh Pharma Ltd Share Price Today

The Anuh Pharma Ltd share price today is ₹86.31. During the trading session, the Anuh Pharma Ltd share price opened at ₹87 and recorded an intraday high of ₹88.94 and a low of ₹84.42. Last closing price was ₹87.4. Over the past 52 weeks, the Anuh Pharma Ltd share price has ranged between ₹67 and ₹99.5. The current Anuh Pharma Ltd stock price reflects real-time market activity based on executed trades on the exchange.